
Consytel Life Sciences (P) Ltd is a deep life science startup focused on addressing unmet therapeutic needs through multimodal solutions. They operate across three verticals: Formulations, Biopharmaceuticals, and Medical Devices. Their key product focus includes Opunika®, a natural anti-malarial product derived from Punica granatum rind, which has demonstrated therapeutic and preventive efficacy. Consytel is also developing AI-driven, IoT-enabled medical devices for vector control and is working on biopharmaceuticals for allergy and immunology, as well as functional nutraceuticals. The company is incubated at Atal Incubation Centre (AIC-CCMB) in India and aims to enhance wellness and wellbeing by changing the way of living.

Consytel Life Sciences (P) Ltd is a deep life science startup focused on addressing unmet therapeutic needs through multimodal solutions. They operate across three verticals: Formulations, Biopharmaceuticals, and Medical Devices. Their key product focus includes Opunika®, a natural anti-malarial product derived from Punica granatum rind, which has demonstrated therapeutic and preventive efficacy. Consytel is also developing AI-driven, IoT-enabled medical devices for vector control and is working on biopharmaceuticals for allergy and immunology, as well as functional nutraceuticals. The company is incubated at Atal Incubation Centre (AIC-CCMB) in India and aims to enhance wellness and wellbeing by changing the way of living.